MBX vs. ABCN, EMC, FRX, BCT, IPA, SCYB, COM, MDNA, NVH, and IGX
Should you be buying Microbix Biosystems stock or one of its competitors? The main competitors of Microbix Biosystems include VIVO Cannabis (ABCN), Emblem (EMC), Fennec Pharmaceuticals (FRX), BriaCell Therapeutics (BCT), ImmunoPrecise Antibodies (IPA), Scythian Biosciences (SCYB), 138267 (COM.TO) (COM), Medicenna Therapeutics (MDNA), Novoheart (NVH), and IntelGenx Technologies (IGX). These companies are all part of the "biotechnology" industry.
Microbix Biosystems vs.
VIVO Cannabis (CVE:ABCN) and Microbix Biosystems (TSE:MBX) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, analyst recommendations, media sentiment, profitability, community ranking, institutional ownership, earnings, valuation and dividends.
In the previous week, Microbix Biosystems had 4 more articles in the media than VIVO Cannabis. MarketBeat recorded 4 mentions for Microbix Biosystems and 0 mentions for VIVO Cannabis. Microbix Biosystems' average media sentiment score of 0.52 beat VIVO Cannabis' score of 0.00 indicating that Microbix Biosystems is being referred to more favorably in the news media.
VIVO Cannabis received 58 more outperform votes than Microbix Biosystems when rated by MarketBeat users. Likewise, 71.91% of users gave VIVO Cannabis an outperform vote while only 70.71% of users gave Microbix Biosystems an outperform vote.
Microbix Biosystems has higher revenue and earnings than VIVO Cannabis.
0.4% of Microbix Biosystems shares are owned by institutional investors. 14.0% of Microbix Biosystems shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.
Microbix Biosystems has a net margin of 13.86% compared to VIVO Cannabis' net margin of 0.00%. Microbix Biosystems' return on equity of 12.65% beat VIVO Cannabis' return on equity.
Summary
Microbix Biosystems beats VIVO Cannabis on 8 of the 10 factors compared between the two stocks.
Get Microbix Biosystems News Delivered to You Automatically
Sign up to receive the latest news and ratings for MBX and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Microbix Biosystems Competitors List
Related Companies and Tools
This page (TSE:MBX) was last updated on 2/22/2025 by MarketBeat.com Staff
Free MBX Stock Alerts